ILC2-derived IL-9 inhibits colorectal cancer progression by activating CD8(+) T cells. Wan J, Wu Y, Huang L, Tian Y, et al. Cancer Lett 2021 Jan 8. pii: S0304-3835(21)00011.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Wan J, Wu Y, Huang L, Tian Y, et al. ILC2-derived IL-9 inhibits colorectal cancer progression by activating CD8(+) T cells. Cancer Lett 2021 Jan 8. pii: S0304-3835(21)00011.
PMID: 33429004